Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
RBC Enterprise A TETAX
- NAV / 1-Day Return 16.69 / +0.48 %
- Total Assets 69.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.360%
- Distribution Fee Level Above Average
- Share Class Type Front Load
- Category Small Blend
- Investment Style Small Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.16%
- Turnover 28%
USD | NAV as of Sep 28, 2024 | 1-Day Return as of Sep 28, 2024, 12:17 AM GMT+0
Morningstar’s Analysis TETAX
Will TETAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
SPDR® S&P Biotech ETF | 3.44 | 2.3 Mil | — |
Onto Innovation Inc | 3.16 | 2.1 Mil | Technology |
Lantheus Holdings Inc | 3.13 | 2.1 Mil | Healthcare |
UFP Technologies Inc | 3.11 | 2.1 Mil | Healthcare |
Astrana Health Inc | 3.07 | 2.1 Mil | Healthcare |
NAPCO Security Technologies Inc | 2.75 | 1.9 Mil | Industrials |
Ducommun Inc | 2.59 | 1.8 Mil | Industrials |
Surmodics Inc | 2.57 | 1.7 Mil | Healthcare |
MiMedx Group Inc | 2.53 | 1.7 Mil | Healthcare |
iShares Micro-Cap ETF | 2.51 | 1.7 Mil | — |